Receptacle
Latest Senju Pharmaceutical Co., Ltd. Patents:
- SUSPENSION CONTAINING HETEROCYCLIDENE ACETAMIDE DERIVATIVE
- AGENT FOR PROMOTING CORNEAL ENDOTHELIAL CELL ADHESION
- USE OF POLYETHER COMPOUND
- THERAPEUTIC DRUG FOR DISEASES RELATED TO ENDOPLASMIC RETICULUM CELL DEATH IN CORNEAL ENDOTHELIUM
- Therapeutic drug for diseases related to endoplasmic reticulum cell death in corneal endothelium
Description
Claims
The ornamental design of the receptacle, as shown and described.
Referenced Cited
U.S. Patent Documents
2896237 | July 1959 | Owens et al. |
5056689 | October 15, 1991 | Heyl et al. |
D338159 | August 10, 1993 | Densky et al. |
D355844 | February 28, 1995 | Bishop et al. |
D374613 | October 15, 1996 | Maxwell et al. |
D451396 | December 4, 2001 | Johnson et al. |
D498146 | November 9, 2004 | Densky et al. |
D563798 | March 11, 2008 | Gibson et al. |
20030034322 | February 20, 2003 | Doherty et al. |
Patent History
Patent number: D591168
Type: Grant
Filed: Jan 31, 2008
Date of Patent: Apr 28, 2009
Assignee: Senju Pharmaceutical Co., Ltd.
Inventor: Tadashi Otsuka (Hyogo)
Primary Examiner: Stella M Reid
Assistant Examiner: Shanda C Hill
Attorney: Vedder Price P.C.
Application Number: 29/303,079
Type: Grant
Filed: Jan 31, 2008
Date of Patent: Apr 28, 2009
Assignee: Senju Pharmaceutical Co., Ltd.
Inventor: Tadashi Otsuka (Hyogo)
Primary Examiner: Stella M Reid
Assistant Examiner: Shanda C Hill
Attorney: Vedder Price P.C.
Application Number: 29/303,079
Classifications
Current U.S. Class:
D9/724